(Q33693557)

28 July 2017

1 reference

title

The role of age and cardiovascular disease in glaucomatous optic neuropathy (English)

1 reference

28 July 2017

cardiovascular disease

1 reference

Hayreh SS

1

1 reference

28 July 2017

1 June 1999

1 reference

28 July 2017

Survey of Ophthalmology

1 reference

28 July 2017

43 Suppl 1

1 reference

28 July 2017

S27-42

1 reference

Lessons to be learned from the Collaborative Glaucoma Study

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Diurnal and nocturnal blood pressure drops in patients with focal ischemic glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Nimodipine, a centrally active calcium antagonist, exerts a beneficial effect on contrast sensitivity in patients with normal-tension glaucoma and in control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Investigations into a vascular etiology for low-tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Do patients with low tension glaucoma have particular cardiovascular characteristics?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Some factors in the production of low tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Response of blood flow to warm and cold in normal and low-tension glaucoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Shock-induced optic neuropathy: a cause of nonprogressive glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Use of discriminant analysis. II. Identification of persons with glaucomatous visual field defects

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Studies of factors involved in the production of low tension glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Uniocular Open-Angle Glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Scotoma due to arterial hypotension

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Antihypertensive treatment, myocardial infarction, and nocturnal myocardial ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

The deterioration of the visual field in glaucoma and the blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Proptosis and periorbital edema due to diltiazem treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Influence of nifedipine on the visual fields of patients with optic-nerve-head diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

The influence of magnesium on visual field and peripheral vasospasm in glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Influence of vasospasm on visual function

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Do vasospasms provoke ocular diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Systemic factors in patients with low-tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Ambulatory blood pressure monitoring in glaucoma. The nocturnal dip.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

[Glaucoma without ocular hypertension. A clinical study]

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

The relationship between digital and ocular vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Hemodynamic and visual function effects of oral nifedipine in patients with normal-tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Anterior ischaemic optic neuropathy. I. Terminology and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Duke-elder lecture. Systemic arterial blood pressure and the eye.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Ophthalmic arterial and venous pressures. Effects of acute intracranial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Serotonin-induced constriction of ocular arteries in atherosclerotic monkeys. Implications for ischemic disorders of the retina and optic nerve head

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Nonarteritic anterior ischemic optic neuropathy: time of onset of visual loss

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Role of nocturnal arterial hypotension in optic nerve head ischemic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Vasogenic origin of visual field defects and optic nerve changes in glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Fundus lesions in malignant hypertension. III. Arterial blood pressure, biochemical, and fundus changes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Nonarteritic Anterior Ischemic Optic Neuropathy: Role of Nocturnal Arterial Hypotension

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Platelet function, blood coagulability, and fibrinolysis in patients with low tension glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Glaucomatous parapapillary atrophy. Occurrence and correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Optic disc histomorphometry in normal eyes and eyes with secondary angle-closure glaucoma. II. Parapapillary region

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Silent myocardial ischemia in glaucoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Systemic blood pressure in glaucoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

The effect of Ca2(+) -antagonist on visual field in low-tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Direct clinico-histological correlation of parapapillary chorioretinal atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

24-hour blood pressure monitoring in patients with anterior ischemic optic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Systemic blood pressure in open-angle glaucoma, low tension glaucoma, and the normal eye

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

The epidemiology of open-angle glaucoma: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Intraocular pressure, cardiovascular risk variables, and visual field defects

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Low tension glaucoma: a critical review and new material

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Visual field loss in migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Fluorescein angiographic defects of the optic disc in ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Neuroretinal rim area in low tension glaucoma: effect of nifedipine and acetazolamide compared to no treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

A CASE OF PSEUDO-GLAUCOMA.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Soft glaucoma and calcification of the internal carotid arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Twenty four hour blood pressure monitoring in normal tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Calcium channel blockers in the management of low-tension and open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Activation of the coagulation cascade in untreated primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Do calcium channel blockers increase the risk of cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Optic nerve fiber loss in relation to atrial fibrillation and blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Hemodynamic variables in progressive and non-progressive low tension glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

[Effect of nifedipine on ocular pulse amplitude in normal pressure glaucoma]

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Biostatistical evidence for two distinct chronic open angle glaucoma populations

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Hypertension, Perfusion Pressure, and Primary Open-angle Glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Surgical bleeding: unexpected effect of a calcium antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Ophthalmic hazards of hypotensive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

A case-control study of risk factors in open angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Relaxation effects of diltiazem, verapamil, and tolazoline on isolated cat ophthalmociliary artery

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

Management of the primary glaucomas: the Arthur J. Bedell Lecture.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2899%2900018-1

7 January 2021

10.1016/S0039-6257(99)00018-1

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10416745